Rocket Lab Projects Positive Q2 EBITDA, Reversing Prior Loss Forecast
RKLB has more than doubled off its 52-week low of $20.232 on elevated volume (3.6× avg).
Summary
Rocket Lab has issued Q2 2026 guidance, projecting revenue of approximately $232.5 million and, notably, positive adjusted EBITDA of around $23 million. This guidance marks a significant reversal from the company's previous outlook, which anticipated a non-GAAP loss for the quarter. While the headline also references a share resale filing and a multi-launch deal, these appear to be redundant with an 8-K filing on May 8th and a Dow Jones news report on May 7th, respectively. The shift to positive EBITDA is a material positive surprise for investors, signaling improved profitability and operational efficiency, which is a strong catalyst for the stock. Traders will be closely watching the actual Q2 results to validate this improved financial trajectory.
At the time of this announcement, RKLB was trading at $106.00 on NASDAQ in the Technology sector, with a market capitalization of approximately $61B. The 52-week trading range was $20.23 to $105.62. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Wiseek News.